您的位置: 首页 > 文字全文
2023年7月 第38卷 第7期11
目录

中药穴位贴敷联合沙库巴曲缬沙坦对慢性心力衰竭患者中医证候及心功能的影响

Effect of traditional Chinese medicine acupoint application combined with sacubitril/valsartan on TCM syndromes and cardiac function in patients with chronic heart failure

来源期刊: 广州医药 | - 发布时间: 收稿时间:2026/6/16 18:16:18 阅读量:0
作者:
关键词:
慢性心力衰竭;阳虚水泛证;穴位贴敷;沙库巴曲缬沙坦
Chronic heart failure; Yang deficiency and water flooding syndrome; Acupoint application; Sacubitril/valsartan
DOI:
收稿时间:
 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 分析中药穴位贴敷、沙库巴曲缬沙坦联合治疗在慢性心力衰竭(CHF)中的应用效果。方法 选取我院CHF患者90例(2024-08—2026-01),依据随机数字表分成两组,每组45例。对照组接受沙库巴曲缬沙坦治疗,研究组接受中药穴位贴敷联合沙库巴曲缬沙坦治疗。观察两组疗效、6min步行距离、中医证候积分、心功能[心脏指数(CI)、每搏输出量(SV)、左室射血分数(LVEF)]、心肌指标[脑钠肽(BNP)、肌钙蛋白Ⅰ(cTnⅠ)]、安全性。结果 研究组治疗效果优于对照组(P<0.05);治疗后,研究组中医证候积分、BNP、cTnⅠ低于对照组,6min步行距离、LVEF、CI、SV高于对照组(P<0.05);两组治疗期间不良反应无显著差异(P>0.05)。结论 中药穴位贴敷联合沙库巴曲缬沙坦治疗CHF效果显著,可减轻临床症状,改善心功能,减少心肌损伤。
Objective To analyze the clinical efficacy of combined therapy with traditional Chinese medicine acupoint application and sacubitril/valsartan in patients with chronic heart failure (CHF). Methods A total of 90 patients with CHF admitted to our Hospital from August 2024 to January 2026 were selected, and divided into two groups by random number table, with 45 cases in each group. The control group was treated with sacubitril/valsartan, while the study group received combined therapy of traditional Chinese medicine acupoint application and sacubitril/valsartan. The therapeutic efficacy, 6-minute walking distance, TCM syndrome score, cardiac function indexes [cardiac index (CI), stroke volume (SV), left ventricular ejection fraction (LVEF)], myocardial indicators [brain natriuretic peptide (BNP), cardiac troponin Ⅰ (cTnⅠ)] and safety were observed in both groups. Results The therapeutic efficacy of the study group was better than that of the control group (P<0.05). After treatment, the TCM syndrome scores, BNP and cTnⅠ levels in the observation group were lower, while the 6-minute walking distance, LVEF, CI and SV were higher compared with the control group (P<0.05). No significant between-group difference was found in adverse reactions during treatment (P>0.05). Conclusion Traditional Chinese medicine acupoint application combined with sacubitril/valsartan achieves remarkable efficacy in the treatment of CHF. It can relieve clinical symptoms, improve cardiac function and alleviate myocardial injury.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录